E-nitiate Biopharmaceuticals

About:

E-nitiate Biopharmaceuticals is committed to the development of innovative drugs for autoimmune diseases, through independent research.

Website: http://www.enitiatebio.com/en.php/

Top Investors: TaiKun Fund, LPSCO, Hangzhou Jintou Industrial Fund, Betta Pharmaceuticals

Description:

E-nitiate Biopharmaceuticals is committed to the development of innovative drugs for autoimmune diseases, through independent research and development, and strategic collaborations, to address unmet medical needs and to improve the quality of human life.

Total Funding Amount:

$17.3M

Headquarters Location:

Hangzhou, Zhejiang, China

Founded Date:

2020-01-01

Contact Email:

qiyuanshengwu(AT)enitiatebio.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2022-09-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai